Navigation Links
Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
Date:10/27/2009

. In the pivotal clinical development program, patients treated with rilonacept reported a greater improvement in overall symptom scores than patients treated with placebo. These improvements were sustained over time with continued rilonacept treatment. Patients reported their symptoms using a validated daily diary instrument. These assessments represent a critical measure of effectiveness in a disease characterized by frequent, unpredictable symptom flares of variable severity and duration. Unlike other agents used in the treatment of CAPS, rilonacept is supported by patient-reported symptoms data using a validated assessment instrument.

Rilonacept has been developed as a once-weekly injection which can be administered at home by the patient or their care giver following appropriate training. The most commonly reported adverse reactions with rilonacept were injection-site reaction and upper respiratory tract infection. IL-1 blockade may interfere with immune response to infections and treatment should not be initiated in patients with active or chronic infections. There have been reports of serious, life-threatening infections in patients taking rilonacept. Rilonacept should be discontinued if a patient develops a serious infection.

The authorization for approval of rilonacept in the E.U. under exceptional circumstances is permissible for products for which a company can demonstrate that comprehensive data cannot be provided, for example because of the rarity of the condition. Each year, Regeneron will need to provide the EMEA with any new information that may become available for review.

About Cryopyrin-Associated Periodic Syndromes (CAPS)

Recently, medical researchers have identified and described a group of rare, inherited, auto-inflammatory disorders, known as Cryopyrin-Associated Periodic Syndromes or CAPS. Three related conditions make up the broader disease known as CAPS: Familial Cold Aut
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Celsis IVT Granted U.S. Patent for LiverPool(TM) Hepatocytes
2. Peripheral Artery Disease (PAD) Patent Granted to Dimera
3. Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai
4. Delcath Systems Granted Third Orphan Drug Designation
5. Fate Therapeutics Granted Exclusive License for Stem Cell Modulators by Childrens Hospital Boston and Massachusetts General Hospital
6. FDA has Granted HUD (Humanitarian Use Device) Designation to ITGIs Pericardium Covered Stents, Over and Under(R) and Aneugraft(R), for Treatment of Perforations and Dissections of Native Coronary Arteries and Saphenous Vein Grafts
7. Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation
8. Tolera Therapeutics Granted Orphan Drug Designation for Organ Transplant Rejection Drug
9. VIASPACE Granted US Patent
10. Crisis Exemption Granted to Market Avipel(R) Corn Seed Treatment in Louisiana
11. Valdoxan(R) Granted Marketing Authorisation for the Treatment of Major Depressive Episodes in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 2015 The Pistoia Alliance, a global, ... to lower barriers to innovation in R&D, has announced ... , The Ontologies Mapping project has been set up ... ontology management in life sciences R&D. The project will ... guidelines, tools and services to enable the universal application ...
(Date:4/28/2015)... 2015 uBiome, Inc. has announced ... provide clinical tests based on its unique microbial ... startup sparked the era of microbiome-based personalized medicine ... accessible information about their own bodies using the ... microbiome. uBiome has gathered millions of data points ...
(Date:4/28/2015)... More than 50% of patients with ... over the course of their disease, and clinicians are ... the disease progresses. ReachMD , the 24/7 health ... a series dedicated to PD psychosis, featuring interviews and ... and psychiatric conditions. , The new series titled ...
(Date:4/28/2015)... April 28, 2015 IMS is ... bring it to the web and provide greater ... user friendly reporting metrics increase data warehouse’s utility; ... convenient recall and access “on-the-go” makes data analysis ... using client feedback to assist in repository analytics ...
Breaking Biology Technology:Pistoia Alliance Announces Start of Ontologies Mapping Project 2uBiome Launches Clinical Laboratory 2ReachMD Launches Series Focusing on Parkinson’s Disease Psychosis 2
... Wis. Berbee Information Networks Corporation , a ... & Solutions LLC for an undisclosed sum. , ,Berbee said ... firm, bringing it to about 630 employees in all. Strategies ... IBM's iSeries line of business servers. , ,Berbee has ...
... new version of its Mediasite presentation recorder for the Japanese ... date and hopes to create a bigger market. , ,Mediasite ... as a PowerPoint deck with a video of the speaker ... , ,According to company statements the Japanese market is attractive ...
... Manufacturing Company in Racine is providing heat-transfer components ... , the company said on Wednesday. , ,The parts ... company's new hybrid vehicle. Modine's mass heat transfer ... which is the car's main energy source. , ,The ...
Cached Biology Technology:Modine explores making components for fuel cell vehicles 2Modine explores making components for fuel cell vehicles 3
(Date:4/27/2015)... ATLANTA , April 27, 2015  For more ... and trade show has been the premier worldwide event ... Systems 2015 is a must-attend event for any local, ... insight into the emerging commercial markets and current applications ... and innovations of this projected $48 billion industry, and ...
(Date:4/27/2015)... OXFORD, Conn. , Apr. 27, 2015 ... "Company"), a biometric authentication company focused on the growing ... will commence shipping to pre-order customers the first week ... pre-orders through the month of May. ... is a significant milestone for the company as Wocket® ...
(Date:4/27/2015)... 2015 Profile Solutions, Inc. (OTC: PSIQ), a ... is pleased to announce that Dr Gerry Bedore ... member of its scientific advisory board. ... thought leader in technology-enhanced learning models. He was a ... published studies and books focused on online student success ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... thrive in extreme situations---surviving on toxic chemicals, for instance. ... the American Chemical Society (JACS) May 25, University of ... that: by harnessing other potentially harmful chemicals known as ... , Such insights could lead to new ways of ...
... determined the first detailed molecular images of a piece of ... host cells and initiate the first stages of infection. The ... may help scientists learn new details about how the virus ... potential weak points that can be exploited by novel antiviral ...
... Albert Einstein College of Medicine have discovered a novel ... soon be able to resist the effects of antibiotics ... microbes, including Shigella and E. coli, are rapidly becoming ... led by Dr. John S. Blanchard, the Dan Danciger ...
Cached Biology News:A radical solution for environmental pollution 2Learning how SARS spikes its quarry 2Learning how SARS spikes its quarry 3Einstein researchers identify new way that bacteria develop resistance to antibiotics 2